If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRWS Holdings Regulatory News (RWS)

Share Price Information for RWS Holdings (RWS)

Share Price is delayed by 15 minutes
Get Live Data
75.65    -1.05 (-1.37%)
Bid:
75.65
Ask:
76.00
Spread: 0.35 (0.463%)
Market Cap: £280.79m
RWS Live PriceLast checked at - London Stock Exchange

Intraday RWS Holdings Share Chart

Director/PDMR Shareholding

24 Sep 2024 07:00

RNS Number : 3277F
RWS Holdings PLC
24 September 2024
 

24 September 2024

 

RWS Holdings plc

Notification and public disclosure of transactions by PDMRs

RWS Holdings plc ("RWS" or "the Company"), a unique world-leading provider of technology-enabled language, content and intellectual property services, announces the grant of a deferred share award (the "Award") to Candida Davies, Chief Financial Officer, on 23 September 2024.

Following the announcement of Ian El-Mokadem's intention to step down as Chief Executive Officer in early 2025, the Board of RWS believes that it is in the best interests of the Company to ensure the retention of Candida Davies as Chief Financial Officer. Before granting the Award, the Company consulted with a number of its largest shareholders who each indicated they were supportive of the proposal.

The Award has a value on grant equal to 75% of Candida's base salary (equating to £307,500) and has been granted under the RWS Holdings plc Long Term Incentive Plan ("LTIP") over 189,908 ordinary shares of 1 pence each in the Company. Under the LTIP rules, 40% of the Award will vest on the first anniversary of the grant date and the remaining 60% of the Award will vest on the second anniversary of the grant date. Given the primary objective of this standalone Award is retention, vesting will be conditional on Candida's continued service, with the Award ordinarily lapsing if she ceases employment ahead of the respective vesting dates.

This announcement is made in accordance with Article 19(3) of the EU Market Abuse Regulation 596/2014 (as incorporated into UK domestic law by the European Union (Withdrawal) Act 2018).

For further information, please contact:

RWS Holdings plc

Ian El-Mokadem, Chief Executive Officer

 

 01753 480200

 

MHP (Financial PR advisor)

Katie Hunt / Eleni Menikou / Catherine Chapman

 

rws@mhpgroup.com

020 3128 8100

07884 494112

Deutsche Numis (Nomad & Joint Broker)

Stuart Skinner / William Wickham

 

 

020 7260 1000

 

Berenberg (Joint Broker)

Ben Wright / Toby Flaux / Milo Bonser

 

020 3207 7800

 

About RWS:

RWS Holdings plc is a unique, world-leading provider of technology-enabled language, content and intellectual property services. Through content transformation and multilingual data analysis, our combination of AI-enabled technology and human expertise helps our clients to grow by ensuring they are understood anywhere, in any language.

Our purpose is unlocking global understanding. By combining cultural understanding, client understanding and technical understanding, our services and technology assist our clients to acquire and retain customers, deliver engaging user experiences, maintain compliance and gain actionable insights into their data and content.

Over the past 20 years we've been evolving our own AI solutions as well as helping clients to explore, build and use multilingual AI applications. With 40+ AI-related patents and more than 100 peer-reviewed papers, we have the experience and expertise to support clients on their AI journey.

We work with over 80% of the world's top 100 brands, more than three-quarters of Fortune's 20 'Most Admired Companies' and almost all of the top pharmaceutical companies, investment banks, law firms and patent filers. Our client base spans Europe, Asia Pacific, Africa and North and South America. Our 65+ global locations across five continents service clients in the automotive, chemical, financial, legal, medical, pharmaceutical, technology and telecommunications sectors.

Founded in 1958, RWS is headquartered in the UK and publicly listed on AIM, the London Stock Exchange regulated market (RWS.L). 

For further information, please visit: www.rws.com.

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Candida Davies

2.

Reason for the notification

a.

Position/status

Chief Financial Officer

b.

Initial notification/Amendment

Initial Announcement

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

RWS Holdings plc

b.

LEI

213800YGBGTTSKUVK111

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type

of instrument

Identification code

Ordinary shares of 1p each

GB00BVFCZV34

b.

Nature of the transaction

Grant of nil cost options under the RWS Holdings plc Long Term Incentive Plan.

c.

Price(s) and volume(s)

 

Price(s)

 Nil

Volume(s)

189,908

d.

Aggregated information

·   Aggregated volume

·   Price

 

N/A single transaction

e.

Date of the transaction

23 September 2024

f.

Place of the transaction

Outside of a trading venue

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHQKNBNFBKDDCB
Date   Source Headline
31st Jan 20247:00 amRNSTransaction in Own Shares
30th Jan 20247:00 amRNSTransaction in Own Shares
29th Jan 20247:00 amRNSTransaction in Own Shares
26th Jan 20248:20 amRNSHolding(s) in Company
26th Jan 20247:00 amRNSTransaction in Own Shares
25th Jan 20247:00 amRNSDirector/PDMR Shareholding
25th Jan 20247:00 amRNSDirector/PDMR Shareholding
25th Jan 20247:00 amRNSDirector/PDMR Shareholding
25th Jan 20247:00 amRNSTransaction in Own Shares
24th Jan 20247:00 amRNSTransaction in Own Shares
23rd Jan 20247:00 amRNSTransaction in Own Shares
22nd Jan 20249:00 amRNSPublication of Annual Report and Notice of AGM
22nd Jan 20247:00 amRNSTransaction in Own Shares
19th Jan 20247:00 amRNSTransaction in Own Shares
18th Jan 20247:00 amRNSTransaction in Own Shares
17th Jan 20247:00 amRNSTransaction in Own Shares
16th Jan 20247:00 amRNSTransaction in Own Shares
15th Jan 20247:00 amRNSTransaction in Own Shares
12th Jan 20247:00 amRNSNon-executive Director Resignation
12th Jan 20247:00 amRNSTransaction in Own Shares
11th Jan 20247:00 amRNSTransaction in Own Shares
10th Jan 20247:00 amRNSTransaction in Own Shares
9th Jan 20247:00 amRNSTransaction in Own Shares
8th Jan 20247:00 amRNSTransaction in Own Shares
5th Jan 20247:00 amRNSTransaction in Own Shares
4th Jan 20247:00 amRNSTransaction in Own Shares
3rd Jan 20247:00 amRNSTransaction in Own Shares
2nd Jan 20247:00 amRNSTotal Voting Rights
2nd Jan 20247:00 amRNSTransaction in Own Shares
29th Dec 202311:20 amRNSAIM Rule 17 Update
29th Dec 20237:00 amRNSTransaction in Own Shares
28th Dec 20237:00 amRNSTransaction in Own Shares
27th Dec 20237:00 amRNSTransaction in Own Shares
22nd Dec 20237:00 amRNSTransaction in Own Shares
21st Dec 20234:10 pmRNSHolding(s) in Company
21st Dec 20237:00 amRNSTransaction in Own Shares
19th Dec 20237:00 amRNSTransaction in Own Shares
18th Dec 20237:00 amRNSTransaction in Own Shares
15th Dec 20237:00 amRNSTransaction in Own Shares
14th Dec 20237:00 amRNSAppointment of Non-executive Directors
14th Dec 20237:00 amRNSTransaction in Own Shares
13th Dec 20237:00 amRNSTransaction in Own Shares
12th Dec 20237:00 amRNSAnnual Financial Report
12th Dec 20237:00 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSTransaction in Own Shares
8th Dec 20237:00 amRNSTransaction in Own Shares
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.